<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Inhibitors of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and of excitotoxic cell <z:hpo ids='HP_0011420'>death</z:hpo> reduce brain damage after transient and permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We compared the neuroprotective effects of two caspase family inhibitors with the <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (+)-MK-801 hydrogen maleate (MK-801) in a newly characterized <z:chebi fb="0" ids="27641">cycloheximide</z:chebi>-sensitive murine model of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (30 minutes) in which apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> is prominent </plain></SENT>
<SENT sid="2" pm="."><plain>Ischemic infarction, undetected by 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining at 24-hour reperfusion, featured prominently in the striatum at 72 hours and 7 days on <z:chebi fb="1" ids="51686">hematoxylin</z:chebi>-eosin-stained sections </plain></SENT>
<SENT sid="3" pm="."><plain>Markers of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, such as oligonucleosomal DNA damage (laddering) and terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi>-<z:chebi fb="1" ids="15956">biotin</z:chebi> nick-end labeling (TUNEL)-positive cells first appeared at 24 hours and increased significantly at 72 hours and 7 days after reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>The TUNEL-labeled cells were mostly neurons and stained negative for glial (GFAP, glial fibrillary acid protein) and leukocyte specific markers (CD-45) </plain></SENT>
<SENT sid="5" pm="."><plain>The caspase inhibitors, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl <z:chebi fb="3" ids="17087">ketone</z:chebi> (z-VAD.FMK; 120 ng intracerebroventricularly) or N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl <z:chebi fb="3" ids="17087">ketone</z:chebi> (z-DEVD.FMK; 480 ng intracerebroventricularly) decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> size and neurologic deficits when administered 6 hours after reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>The extent of protection was greater than in models of more prolonged <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> or after permanent occlusion, and the therapeutic window was extended from 0 to 1 hours after 2-hour middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> to at least 6 hours after brief <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Also, z-VAD.FMK and z-DEVD.FMK treatment decreased oligonucleosomal DNA damage (DNA laddering) as assessed by quantitative autoradiography after gel electrophoresis </plain></SENT>
<SENT sid="8" pm="."><plain>By contrast, MK-801 protected brain tissue only when given before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (3 mg/kg intraperitoneally), but not at 3 or 6 hours after reperfusion </plain></SENT>
<SENT sid="9" pm="."><plain>Despite a decrease in <z:mpath ids='MPATH_124'>infarct</z:mpath> size after MK-801 pretreatment, the amount of DNA laddering did not decrease 72 hours after reperfusion, thereby suggesting a mechanism distinct from inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>Hence, 30 minutes of reversible <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> augments apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo>, which can be attenuated by delayed z-VAD.FMK and z-DEVD.FMK administration with preservation of neurologic function </plain></SENT>
<SENT sid="11" pm="."><plain>By contrast, the therapeutic window for MK-801 does not extend beyond the time of occlusion, probably because its primary mechanism of action does not block the development of apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>